Shrestha, A, Bashir, T, Achison, M, Adamson, S, Akpan, A, Aspray, T, Avenell, A, Band, M. M., Burton, L. A., Cvoro, V, Donnan, P. T., Duncan, G. W., George, Gordon, A. L., Gregson, C. L., Hapca, A, Hume, C, Jackson, T. A., Kerr, S, Kilgour, A, Masud, T, McKenzie, A, McKenzie, E, Patel, H, Pilvinyte, K, Roberts, H. C., Sayer, A. A., Rossios, C, Smith, K. T., Soiza, R. L., Steves, C. J., Struthers, A. D., Tiwari, D, Whitney, J, Witham, M. D. & Kemp, P. R. (2024). Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial. PLOS ONE, 19 (8), e0307268. Zugriff am 30.09.2024 unter https://doi.org/10.1371/journal.pone.0307268
APA-Zitierstil (7. Ausg.)Shrestha, A., Bashir, T., Achison, M., Adamson, S., Akpan, A., Aspray, T., . . . Kemp, P. R. (2024). Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial. PLOS ONE, 19(8), e0307268.
Chicago-Zitierstil (17. Ausg.)Shrestha, A., et al. "Association of Bradykinin Receptor 2 (BDKRB2) Variants with Physical Performance and Muscle Mass: Findings from the LACE Sarcopenia Trial." PLOS ONE 19, no. 8 (2024): e0307268.
MLA-Zitierstil (9. Ausg.)Shrestha, A., et al. "Association of Bradykinin Receptor 2 (BDKRB2) Variants with Physical Performance and Muscle Mass: Findings from the LACE Sarcopenia Trial." PLOS ONE, vol. 19, no. 8, 2024, p. e0307268.